Cannabis
DisposeRx Announces the Expansion of DisposeRx Direct at Rx Summit 2022
DisposeRx, Inc. will begin offering products from Rx Destroyer on its online store, DisposeRx Direct, at the Rx Drug Abuse and Heroin Summit (Rx Summit), April 18-21, 2022, in Atlanta.
Rx Summit is the largest, most influential annual conference addressing the opioid and addiction crisis, and DisposeRx is a gold sponsor. This year’s theme is “It’s Time to Turn This Epidemic Around,” and DisposeRx and Rx Destroyer executives are teaming up to help battle the drug misuse epidemic through medication disposal and education.
“DisposeRx and Rx Destroyer are coming together to share with conference participants comprehensive medication disposal options designed to meet virtually all needs—from individual prescriptions to large quantities,” said William Simpson, president and chief executive officer of DisposeRx, Inc. “We share the same mission, commitment to outstanding customer service and passion for this industry, and we are proud to work together to remove the risks and dangers associated with unused and leftover medications.”
DisposeRx Direct—a wholly-owned subsidiary of DisposeRx, Inc., now includes several of Rx Destroyer’s most popular disposal solutions for large quantities of medications. The companies will showcase their products in Booth 319.
“Rx Summit is a chance to show the world that two businesses that share marketspace can come together for the greater good and especially in the fight to end opioid abuse,” said Milton Dallas, CEO for Rx Destroyer. “Showcasing our products together demonstrates that there are several ways to make a difference, and we must have the will and courage to do so. Some things are bigger than just what is in front of us. Making the world a better place for our loved ones for generations to come is our obligation and responsibility, and this demonstration of both companies’ products is just one of many ways we can make this happen.”
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Cannabis1 week ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
transfer1 week ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis1 week ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis1 week ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®2 weeks ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan4 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf4 days ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis4 days ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care